| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2024 | Jun 26, 2024 | Inmune Bio, Inc. | Director | Buy | 86.3 | +5,000 | 7.51% | ✗ | $36.4K |
| Apr 19, 2024 | Apr 24, 2024 | Inmune Bio, Inc. | Director | Buy | 95.0 | +29,603 | 80.01% | ✗ | $246.3K |
| Nov 10, 2023 | Nov 13, 2023 | Inmune Bio, Inc. | Director | Buy | 91.3 | +7,000 | 23.33% | ✗ | $48.7K |
| Nov 17, 2021 | Nov 17, 2021 | Inmune Bio, Inc. | Director | Buy | 86.3 | +2,500 | 9.09% | ✗ | $33.9K |
| Aug 20, 2019 | Aug 22, 2019 | Inmune Bio, Inc. | Director | Buy | 91.3 | +5,000 | 22.22% | ✗ | $30K |
| Jun 3, 2019 | Jun 4, 2019 | Inmune Bio, Inc. | Director | Buy | 95.0 | +10,000 | 80.00% | ✗ | $60K |